Disclosure under Regulation 30 of SEBI (LODR) Regualtions, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Oxygenta Pharmaceutical Ltd has informed the stock exchange about two key resignations effective 18 August 2025. Mr. Vankineni Sai Sudhakar (DIN: 00733001) stepped down from his dual role as Managing Director and Chief Financial Officer, citing a change in ownership and management of the company. Separately, Mr. Sanagari Kondal Reddy (DIN: 02530466) also resigned as Independent Director for the same reason — a takeover of the company. Both resignations are voluntary and both outgoing directors confirmed there are no other material reasons for their exit. The company is a subsidiary of Virupaksha Organics Limited.
The resignations of the MD, CFO, and an Independent Director — all triggered by a takeover — suggest new management is taking control. Shareholders should expect a Board reconstitution soon and watch for fresh appointments that could signal the new owner's strategic direction for the company.